SULLIVAN CHRISTOPHER RYAN (Interim CFO) sold 97.6% of their position (16.91K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market sale worth $222.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/1/2026ACC: 0001810417-26-000008
Officer· Interim CFO
Since Apr 2020
-16.91K
Net shares
Net seller
$222.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
16.91K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−8.46K
Price / share
$13.09
Trade value
$110.74K
% of position
48.8%
4/29/2026
17.34K→8.88K
Common Stock
Direct
Shares
−8.46K
Price / share
$13.23
Trade value
$111.85K
% of position
95.2%
4/30/2026
8.88K→423.00
Total
Net shares
−16.91K
Net value
-$222.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/29/2026 | S · Sale | −8.46K | $13.09 | $110.74K | 48.8% | 17.34K | 8.88K |
| Common Stock Direct | 4/30/2026 | S · Sale | −8.46K | $13.23 | $111.85K | 95.2% | 8.88K | 423.00 |
| Total | −16.91K | -$222.59K | ||||||
Derivative Transactions0
No derivative transactions reported